 | • レポートコード：QFJ1-5802 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、インフルエンザ用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・インフルエンザ用治療薬の市場動向 ・企業の競争状況、市場シェア ・インフルエンザ用治療薬の種類別市場規模と予測2016-2027（オセルタミビル、ザナミビル、ペラミビル、その他） ・インフルエンザ用治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・インフルエンザ用治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・インフルエンザ用治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・インフルエンザ用治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・インフルエンザ用治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・インフルエンザ用治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、AstraZeneca、Eli Lilly、Roche、GlaxoSmithKline、Novartis、Pfizer、Sanofi Pasteur、Bayer、Celgene、Seqirus、Protein Sciences Corporation、Serum Institute of India、Emergent Biosolutions、BioCryst Pharmaceuticals、Alvogen） ・結論 |
Market Analysis and Insights: Global Influenza Drugs Market
The global Influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Drugs market.
Global Influenza Drugs Scope and Market Size
Influenza Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oseltamivir
Zanamivir
Peramivir
Other
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oseltamivir
1.2.3 Zanamivir
1.2.4 Peramivir
1.2.5 Other
1.3 Market by Application
1.3.1 Global Influenza Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Influenza Drugs Market Perspective (2016-2027)
2.2 Influenza Drugs Growth Trends by Regions
2.2.1 Influenza Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Influenza Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Influenza Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Influenza Drugs Industry Dynamic
2.3.1 Influenza Drugs Market Trends
2.3.2 Influenza Drugs Market Drivers
2.3.3 Influenza Drugs Market Challenges
2.3.4 Influenza Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Drugs Players by Revenue
3.1.1 Global Top Influenza Drugs Players by Revenue (2016-2021)
3.1.2 Global Influenza Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Drugs Revenue
3.4 Global Influenza Drugs Market Concentration Ratio
3.4.1 Global Influenza Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Drugs Revenue in 2020
3.5 Influenza Drugs Key Players Head office and Area Served
3.6 Key Players Influenza Drugs Product Solution and Service
3.7 Date of Enter into Influenza Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Drugs Breakdown Data by Type
4.1 Global Influenza Drugs Historic Market Size by Type (2016-2021)
4.2 Global Influenza Drugs Forecasted Market Size by Type (2022-2027)
5 Influenza Drugs Breakdown Data by Application
5.1 Global Influenza Drugs Historic Market Size by Application (2016-2021)
5.2 Global Influenza Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Influenza Drugs Market Size (2016-2027)
6.2 North America Influenza Drugs Market Size by Type
6.2.1 North America Influenza Drugs Market Size by Type (2016-2021)
6.2.2 North America Influenza Drugs Market Size by Type (2022-2027)
6.2.3 North America Influenza Drugs Market Size by Type (2016-2027)
6.3 North America Influenza Drugs Market Size by Application
6.3.1 North America Influenza Drugs Market Size by Application (2016-2021)
6.3.2 North America Influenza Drugs Market Size by Application (2022-2027)
6.3.3 North America Influenza Drugs Market Size by Application (2016-2027)
6.4 North America Influenza Drugs Market Size by Country
6.4.1 North America Influenza Drugs Market Size by Country (2016-2021)
6.4.2 North America Influenza Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Influenza Drugs Market Size (2016-2027)
7.2 Europe Influenza Drugs Market Size by Type
7.2.1 Europe Influenza Drugs Market Size by Type (2016-2021)
7.2.2 Europe Influenza Drugs Market Size by Type (2022-2027)
7.2.3 Europe Influenza Drugs Market Size by Type (2016-2027)
7.3 Europe Influenza Drugs Market Size by Application
7.3.1 Europe Influenza Drugs Market Size by Application (2016-2021)
7.3.2 Europe Influenza Drugs Market Size by Application (2022-2027)
7.3.3 Europe Influenza Drugs Market Size by Application (2016-2027)
7.4 Europe Influenza Drugs Market Size by Country
7.4.1 Europe Influenza Drugs Market Size by Country (2016-2021)
7.4.2 Europe Influenza Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Influenza Drugs Market Size (2016-2027)
8.2 Asia-Pacific Influenza Drugs Market Size by Type
8.2.1 Asia-Pacific Influenza Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Influenza Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Influenza Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Influenza Drugs Market Size by Application
8.3.1 Asia-Pacific Influenza Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Influenza Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Influenza Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Influenza Drugs Market Size by Region
8.4.1 Asia-Pacific Influenza Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Influenza Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Influenza Drugs Market Size (2016-2027)
9.2 Latin America Influenza Drugs Market Size by Type
9.2.1 Latin America Influenza Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Influenza Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Influenza Drugs Market Size by Type (2016-2027)
9.3 Latin America Influenza Drugs Market Size by Application
9.3.1 Latin America Influenza Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Influenza Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Influenza Drugs Market Size by Application (2016-2027)
9.4 Latin America Influenza Drugs Market Size by Country
9.4.1 Latin America Influenza Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Influenza Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Drugs Market Size (2016-2027)
10.2 Middle East & Africa Influenza Drugs Market Size by Type
10.2.1 Middle East & Africa Influenza Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Influenza Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Influenza Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Influenza Drugs Market Size by Application
10.3.1 Middle East & Africa Influenza Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Influenza Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Influenza Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Influenza Drugs Market Size by Country
10.4.1 Middle East & Africa Influenza Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Influenza Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Influenza Drugs Introduction
11.1.4 Bristol-Myers Squibb Revenue in Influenza Drugs Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Influenza Drugs Introduction
11.2.4 AstraZeneca Revenue in Influenza Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Influenza Drugs Introduction
11.3.4 Eli Lilly Revenue in Influenza Drugs Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Influenza Drugs Introduction
11.4.4 Roche Revenue in Influenza Drugs Business (2016-2021)
11.4.5 Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Influenza Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Influenza Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Influenza Drugs Introduction
11.6.4 Novartis Revenue in Influenza Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Influenza Drugs Introduction
11.7.4 Pfizer Revenue in Influenza Drugs Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Company Details
11.8.2 Sanofi Pasteur Business Overview
11.8.3 Sanofi Pasteur Influenza Drugs Introduction
11.8.4 Sanofi Pasteur Revenue in Influenza Drugs Business (2016-2021)
11.8.5 Sanofi Pasteur Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Influenza Drugs Introduction
11.9.4 Bayer Revenue in Influenza Drugs Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Celgene
11.10.1 Celgene Company Details
11.10.2 Celgene Business Overview
11.10.3 Celgene Influenza Drugs Introduction
11.10.4 Celgene Revenue in Influenza Drugs Business (2016-2021)
11.10.5 Celgene Recent Development
11.11 Seqirus
11.11.1 Seqirus Company Details
11.11.2 Seqirus Business Overview
11.11.3 Seqirus Influenza Drugs Introduction
11.11.4 Seqirus Revenue in Influenza Drugs Business (2016-2021)
11.11.5 Seqirus Recent Development
11.12 Protein Sciences Corporation
11.12.1 Protein Sciences Corporation Company Details
11.12.2 Protein Sciences Corporation Business Overview
11.12.3 Protein Sciences Corporation Influenza Drugs Introduction
11.12.4 Protein Sciences Corporation Revenue in Influenza Drugs Business (2016-2021)
11.12.5 Protein Sciences Corporation Recent Development
11.13 Serum Institute of India
11.13.1 Serum Institute of India Company Details
11.13.2 Serum Institute of India Business Overview
11.13.3 Serum Institute of India Influenza Drugs Introduction
11.13.4 Serum Institute of India Revenue in Influenza Drugs Business (2016-2021)
11.13.5 Serum Institute of India Recent Development
11.14 Emergent Biosolutions
11.14.1 Emergent Biosolutions Company Details
11.14.2 Emergent Biosolutions Business Overview
11.14.3 Emergent Biosolutions Influenza Drugs Introduction
11.14.4 Emergent Biosolutions Revenue in Influenza Drugs Business (2016-2021)
11.14.5 Emergent Biosolutions Recent Development
11.15 BioCryst Pharmaceuticals
11.15.1 BioCryst Pharmaceuticals Company Details
11.15.2 BioCryst Pharmaceuticals Business Overview
11.15.3 BioCryst Pharmaceuticals Influenza Drugs Introduction
11.15.4 BioCryst Pharmaceuticals Revenue in Influenza Drugs Business (2016-2021)
11.15.5 BioCryst Pharmaceuticals Recent Development
11.16 Alvogen
11.16.1 Alvogen Company Details
11.16.2 Alvogen Business Overview
11.16.3 Alvogen Influenza Drugs Introduction
11.16.4 Alvogen Revenue in Influenza Drugs Business (2016-2021)
11.16.5 Alvogen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Influenza Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oseltamivir
Table 3. Key Players of Zanamivir
Table 4. Key Players of Peramivir
Table 5. Key Players of Other
Table 6. Global Influenza Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Influenza Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Influenza Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Influenza Drugs Market Share by Regions (2016-2021)
Table 10. Global Influenza Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Influenza Drugs Market Share by Regions (2022-2027)
Table 12. Influenza Drugs Market Trends
Table 13. Influenza Drugs Market Drivers
Table 14. Influenza Drugs Market Challenges
Table 15. Influenza Drugs Market Restraints
Table 16. Global Influenza Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Influenza Drugs Market Share by Players (2016-2021)
Table 18. Global Top Influenza Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs as of 2020)
Table 19. Ranking of Global Top Influenza Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Influenza Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Influenza Drugs Product Solution and Service
Table 23. Date of Enter into Influenza Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Influenza Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Influenza Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Influenza Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Influenza Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Influenza Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Influenza Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Influenza Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Influenza Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Influenza Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Influenza Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Influenza Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Influenza Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Influenza Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Influenza Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Influenza Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Influenza Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Influenza Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bristol-Myers Squibb Company Details
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Influenza Drugs Product
Table 66. Bristol-Myers Squibb Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Influenza Drugs Product
Table 71. AstraZeneca Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Eli Lilly Company Details
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Influenza Drugs Product
Table 76. Eli Lilly Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Influenza Drugs Product
Table 81. Roche Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Influenza Drugs Product
Table 86. GlaxoSmithKline Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Influenza Drugs Product
Table 91. Novartis Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Influenza Drugs Product
Table 96. Pfizer Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Sanofi Pasteur Company Details
Table 99. Sanofi Pasteur Business Overview
Table 100. Sanofi Pasteur Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 101. Sanofi Pasteur Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Influenza Drugs Product
Table 105. Bayer Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 106. Bayer Recent Development
Table 107. Celgene Company Details
Table 108. Celgene Business Overview
Table 109. Celgene Influenza Drugs Product
Table 110. Celgene Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 111. Celgene Recent Development
Table 112. Seqirus Company Details
Table 113. Seqirus Business Overview
Table 114. Seqirus Influenza Drugs Product
Table 115. Seqirus Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 116. Seqirus Recent Development
Table 117. Protein Sciences Corporation Company Details
Table 118. Protein Sciences Corporation Business Overview
Table 119. Protein Sciences Corporation Influenza Drugs Product
Table 120. Protein Sciences Corporation Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 121. Protein Sciences Corporation Recent Development
Table 122. Serum Institute of India Company Details
Table 123. Serum Institute of India Business Overview
Table 124. Serum Institute of India Influenza Drugs Product
Table 125. Serum Institute of India Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 126. Serum Institute of India Recent Development
Table 127. Emergent Biosolutions Company Details
Table 128. Emergent Biosolutions Business Overview
Table 129. Emergent Biosolutions Influenza Drugs Product
Table 130. Emergent Biosolutions Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 131. Emergent Biosolutions Recent Development
Table 132. BioCryst Pharmaceuticals Company Details
Table 133. BioCryst Pharmaceuticals Business Overview
Table 134. BioCryst Pharmaceuticals Influenza Drugs Product
Table 135. BioCryst Pharmaceuticals Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 136. BioCryst Pharmaceuticals Recent Development
Table 137. Alvogen Company Details
Table 138. Alvogen Business Overview
Table 139. Alvogen Influenza Drugs Product
Table 140. Alvogen Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
Table 141. Alvogen Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oseltamivir Features
Figure 3. Zanamivir Features
Figure 4. Peramivir Features
Figure 5. Other Features
Figure 6. Global Influenza Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Influenza Drugs Report Years Considered
Figure 11. Global Influenza Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Influenza Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Influenza Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Influenza Drugs Market Share by Regions (2022-2027)
Figure 15. Global Influenza Drugs Market Share by Players in 2020
Figure 16. Global Top Influenza Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Influenza Drugs Revenue in 2020
Figure 18. Global Influenza Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Influenza Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Influenza Drugs Market Share by Type (2016-2027)
Figure 22. North America Influenza Drugs Market Share by Application (2016-2027)
Figure 23. North America Influenza Drugs Market Share by Country (2016-2027)
Figure 24. United States Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Influenza Drugs Market Share by Type (2016-2027)
Figure 28. Europe Influenza Drugs Market Share by Application (2016-2027)
Figure 29. Europe Influenza Drugs Market Share by Country (2016-2027)
Figure 30. Germany Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Influenza Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Influenza Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Influenza Drugs Market Share by Region (2016-2027)
Figure 40. China Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Influenza Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Influenza Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Influenza Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Influenza Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Influenza Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Influenza Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 66. Sanofi Pasteur Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 68. Celgene Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 69. Seqirus Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 70. Protein Sciences Corporation Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 71. Serum Institute of India Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 72. Emergent Biosolutions Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 73. BioCryst Pharmaceuticals Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 74. Alvogen Revenue Growth Rate in Influenza Drugs Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界のインフルエンザ用抗ウイルス薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Influenza Antiviral Drugs Market The global Influenza Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…- 世界のインフルエンザ (Flu) 抗ウイルス薬市場規模・現状・予測（2021年-2027年） Antiviral drugs are a class of drugs for the specific treatment of viral infections. Market Analysis and Insights: Global Influenza (Flu) Antiviral Drugs Market The global Influenza (Flu) Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR…
- 世界の犬インフルエンザ治療市場規模・現状・予測（2021年-2027年） Canine influenza is also known as dog flu, and it is a contagious respiratory disease that spreads in an airborne and aerosolized manner in dogs, caused by Type A influenza viruses. Market Analysis and Insights: Global Canine Influenza Treatment Market The global Canine Influenza Treatment market s…
- 世界のペット専用医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pet Speciality Drugs Market The global Pet Speciality Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界のインフルエンザ治療薬市場規模・現状・予測（2021年-2027年） Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus. Market Analysis and Insights: Global Influenza Therapeutics Market The global Influenza Therapeutics market size is projected to reach US$ 9521.1 million by 2027, from US$ 6644.2 million in 2020, at a CAGR o…